A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...
The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
Exagamglogene autotemcel (exa-cel) gene therapy offers a potential cure for severe sickle cell disease, now available on NHS.
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received a pig kidney transplant.
NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...
NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...
Campaigners reacted with joy as health officials approved a gene-editing therapy for certain children and adults with severe sickle cell disorder. It is thought that 1,700 people could be eligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results